Project Grant R34DA057678
Award Date
9/30/22
Completion Date
9/29/25
Dollars Obligated
$1.4M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $882,816 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Rutgers, The State University in New Jersey. The 4-year grant, running from June 1, 2025 to February 28, 2029, will fund research to evaluate the comparative effectiveness of behavioral, pharmacological, and combination treatments for patients with co-occurring post-traumatic stress disorder (PTSD) and substance use disorder (SUD). The research will use...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund the development and evaluation of a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The $2,729,018 award will support a multi-year study to rigorously develop and test a mobile app that provides 24/7 access to...
The National Institute on Drug Abuse (NIDA) awarded a $1,826,522 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to The Medical University of South Carolina to develop and test a digital toolkit to address intimate partner violence (IPV), post-traumatic stress disorder (PTSD), and opioid use disorder (OUD) in opioid treatment programs (OTPs). The project has three aims: 1) conduct stakeholder interviews to inform the development of the digital toolkit for assessing IPV,...
This Project Grant award of $107,002 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to explore the impact of racism-related experiences, including historical trauma, on PTSD symptoms and polysubstance use among Black young adults. The study will measure various forms of racial discrimination (overt, covert, and internalized) as well as historical trauma, and assess their relationship to PTSD and polysubstance use. It...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate an adapted version of Written Exposure Therapy (WET) for treating posttraumatic stress disorder (PTSD) among individuals with opioid use disorder (OUD) in residential substance use disorder (SUD) treatment settings. The $798,605 award will fund a multi-site study to create and test the adapted "Written Exposure in...
This $4.68 million project grant from the National Institute on Drug Abuse, part of the Department of Health and Human Services, will fund research under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The University of Michigan will conduct a prospective cohort study of 400 adults with opioid-involved polysubstance use in Michigan. Researchers will collect detailed weekly data on participants' substance use patterns and motivations over four weeks to understand nuanced profiles...
This $385,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to advance integrated treatment for co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD) in real-world settings. The key objectives are to: Assess the effectiveness of integrated treatment approaches, including first-line medications and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for patients with co-occurring OUD...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to evaluate the therapeutic potential of neuropeptide S receptor 1 (NPSR1) in reducing opioid self-administration and relapse in the context of opioid use disorder (OUD). The $847,000 award, spanning from September 2024 to August 2026, will leverage well-validated preclinical animal models to assess the ability of NPSR1 agonism to alleviate the anxious...
This federal Project Grant award of $683,583 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research to estimate the potential impacts of four alternative methadone treatment (MT) policy scenarios in New York State. The project will use an agent-based computer simulation model to analyze how changes to MT access points, such as through OTPs, mobile units, prescribers, and pharmacies, could influence methadone...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...